These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 30735523)

  • 1. Systematic review and meta-analysis of prognostic microRNA biomarkers for survival outcome in nasopharyngeal carcinoma.
    Sabarimurugan S; Kumarasamy C; Baxi S; Devi A; Jayaraj R
    PLoS One; 2019; 14(2):e0209760. PubMed ID: 30735523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Clinical Update on the Prognostic Effect of microRNA Biomarkers for Survival Outcome in Nasopharyngeal Carcinoma: A Systematic Review and Meta-Analysis.
    Shaw P; Senthilnathan R; Krishnan S; Suresh D; Shetty S; Muthukaliannan GK; Mani RR; Sivanandy P; Chandramoorthy HCK; Gupta MM; Baxi S; Jayaraj R
    Cancers (Basel); 2021 Aug; 13(17):. PubMed ID: 34503179
    [No Abstract]   [Full Text] [Related]  

  • 3. Prognostic Epstein-Barr Virus (EBV) miRNA biomarkers for survival outcome in EBV-associated epithelial malignancies: Systematic review and meta-analysis.
    Abusalah MAH; Irekeola AA; Hanim Shueb R; Jarrar M; Yean Yean C
    PLoS One; 2022; 17(4):e0266893. PubMed ID: 35436288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating MicroRNAs as Prognostic Molecular Biomarkers in Human Head and Neck Cancer: A Systematic Review and Meta-Analysis.
    Lamichhane SR; Thachil T; Gee H; Milic N
    Dis Markers; 2019; 2019():8632018. PubMed ID: 31827646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of microRNAs in head and neck cancers: a systematic review and meta-analysis protocol.
    Kumarasamy C; Devi A; Jayaraj R
    Syst Rev; 2018 Oct; 7(1):150. PubMed ID: 30285880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Investigation of Chemotherapeutic Resistance and miRNA Expressions in Head and Neck Cancers: A Thorough PRISMA Compliant Systematic Review and Comprehensive Meta-Analysis.
    Jayaraj R; Polpaya K; Kunale M; Kodiveri Muthukaliannan G; Shetty S; Baxi S; Mani RR; Paranjothy C; Purushothaman V; Kayarohanam S; Janakiraman AK; Balaraman AK
    Genes (Basel); 2022 Dec; 13(12):. PubMed ID: 36553594
    [No Abstract]   [Full Text] [Related]  

  • 7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic Review and Meta-analysis of the Prognostic Significance of miRNAs in Melanoma Patients.
    Sabarimurugan S; Madurantakam Royam M; Das A; Das S; K M G; Jayaraj R
    Mol Diagn Ther; 2018 Dec; 22(6):653-669. PubMed ID: 30259393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Theragnostic Relationship between Drug-Resistance Specific miRNA Expressions, Chemotherapeutic Resistance, and Sensitivity in Breast Cancer: A Systematic Review and Meta-Analysis.
    Jayaraj R; Nayagam SG; Kar A; Sathyakumar S; Mohammed H; Smiti M; Sabarimurugan S; Kumarasamy C; Priyadharshini T; Gothandam KM; Ramesh N; Gupta A; Baxi S; Swamiappan S; Krishnan S
    Cells; 2019 Oct; 8(10):. PubMed ID: 31615089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of a microRNA signature in nasopharyngeal carcinoma: a microRNA expression analysis.
    Liu N; Chen NY; Cui RX; Li WF; Li Y; Wei RR; Zhang MY; Sun Y; Huang BJ; Chen M; He QM; Jiang N; Chen L; Cho WC; Yun JP; Zeng J; Liu LZ; Li L; Guo Y; Wang HY; Ma J
    Lancet Oncol; 2012 Jun; 13(6):633-41. PubMed ID: 22560814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Five miRNAs as novel diagnostic biomarker candidates for primary nasopharyngeal carcinoma.
    Tang JF; Yu ZH; Liu T; Lin ZY; Wang YH; Yang LW; He HJ; Cao J; Huang HL; Liu G
    Asian Pac J Cancer Prev; 2014; 15(18):7575-81. PubMed ID: 25292031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A four-miRNA signature identified from genome-wide serum miRNA profiling predicts survival in patients with nasopharyngeal carcinoma.
    Liu N; Cui RX; Sun Y; Guo R; Mao YP; Tang LL; Jiang W; Liu X; Cheng YK; He QM; Cho WC; Liu LZ; Li L; Ma J
    Int J Cancer; 2014 Mar; 134(6):1359-68. PubMed ID: 23999999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA expression as a prognostic biomarker of tongue squamous cell carcinoma (TSCC): a systematic review and meta-analysis.
    Sun Y; Li Y; Zhou W; Liu Z
    BMC Oral Health; 2024 Mar; 24(1):406. PubMed ID: 38556858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a 7-microRNA signature in plasma as promising biomarker for nasopharyngeal carcinoma detection.
    Zhang H; Zou X; Wu L; Zhang S; Wang T; Liu P; Zhu W; Zhu J
    Cancer Med; 2020 Feb; 9(3):1230-1241. PubMed ID: 31856390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of matrix metalloproteinase 9 in nasopharyngeal carcinoma: a meta-analysis.
    Liao D; Huang H; Zhu Z; Li T; Li H; Huang GL; He Z
    Minerva Med; 2016 Feb; 107(1):54-61. PubMed ID: 26799856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of pretreatment C-reactive protein/albumin ratio in nasopharyngeal carcinoma: A meta-analysis of published literature.
    Yang X; Liu H; He M; Liu M; Zhou G; Gong P; Ma J; Wang Q; Xiong W; Ren Z; Li X; Zhang X
    Medicine (Baltimore); 2018 Jul; 97(30):e11574. PubMed ID: 30045284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum miRNAs, a potential prognosis marker of loco-regionally advanced nasopharyngeal carcinoma patients treated with CCRT.
    Zhang Z; Huang J; Wang G; Jin F; Zheng J; Xiao H; Lei L; Luo J; Chen C
    BMC Cancer; 2020 Mar; 20(1):183. PubMed ID: 32131777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of two microRNA signatures in whole blood as novel biomarkers for diagnosis of nasopharyngeal carcinoma.
    Wen W; Mai SJ; Lin HX; Zhang MY; Huang JL; Hua X; Lin C; Long ZQ; Lu ZJ; Sun XQ; Liu SL; Yang Q; Zhu Q; Wang HY; Guo L
    J Transl Med; 2019 Jun; 17(1):186. PubMed ID: 31159814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrative data mining and meta-analysis to investigate the prognostic role of microRNA-200 family in various human malignant neoplasms: A consideration on heterogeneity.
    Yuan L; Bing Z; Yan P; Li R; Wang C; Sun X; Yang J; Shi X; Zhang Y; Yang K
    Gene; 2019 Oct; 716():144025. PubMed ID: 31394177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of pretreated serum lactate dehydrogenase level in nasopharyngeal carcinoma among Chinese population: A meta-analysis.
    Zhang M; Wei S; Su L; Lv W; Hong J
    Medicine (Baltimore); 2016 Aug; 95(35):e4494. PubMed ID: 27583859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.